Yes, injection site selection is important for GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
Individual attention to mental health symptoms while using GLP-1 medicines is strongly encouraged
10.1038/sj.cdd.4400316 108 KulikovA
not recommended during pregnancy without supervision
GLP-1 therapies act comprehensively on this metabolic substrate, simultaneously addressing insulin resistance, hepatic inflammation, adipokine dysregulation, and systemic oxidative stress
Healthcare providers can assess whether symptoms represent expected medication effects or require diagnostic evaluation such as stool studies, inflammatory markers (C-reactive protein, fecal calprotectin), or colonoscopy